Company: TPET
Filing Date: 2025-09-04
Form Type: S-3
Source: 0001493152-25-012641
Chunk: 2

Company: Trio Petroleum Corp.
Filing Date: 2025-09-04
Form: S-3
Chunk 2
---
 Shares of Common Stock</div>

This prospectus relates to the resale by the selling stockholders named herein (each a “Selling Stockholder” and collectively, the “Selling Stockholders”), or their respective transferees, pledgees, donees or other successors-in-interest, from time to time, of up to 1,679,127 shares of common stock, par value $0.0001 per share, of Trio Petroleum Corp held by Selling Stockholders consisting of shares of common stock issuable to three institutional investors in connection with convertible promissory notes (the “August 2025 Convertible Notes”) issued to each of them in a financing in which we raised an aggregate of $1,020,000 (collectively, the “Securities”). We are registering the Securities on behalf of the Selling Stockholders, to be offered and sold from time to time, to satisfy certain registration rights that we have granted to the Selling Stockholders.

The Selling Stockholders may resell or dispose of the Securities, or interests therein, at fixed prices, at prevailing market prices at the time of sale or at prices negotiated with purchasers, to or through underwriters, broker-dealers, agents, or through any other means described under the heading “Plan of Distribution” beginning on page 18 of this prospectus. The Selling Stockholders will each bear their respective commissions and discounts, if any, attributable to the sale or disposition of the Securities, or interests therein, held by such Selling Stockholder. We will bear all costs, expenses and fees in connection with the registration of the Securities. We will not receive any of the proceeds from the sale of the Securities by the Selling Stockholders.

Our common stock is listed on the NYSE American under the symbol “TPET.” On September 2, 2025, the last reported sale price of our common stock on the NYSE American was $1.14 per share.

Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading “Risk Factors” beginning on page 10 of this prospectus, contained in the applicable prospectus supplement and in any related free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus or any prospectus supplement before making a decision to purchase our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is